100profile quality
Germany's second-largest drugstore chain with a focus on affordable consumer goods and sustainability.
Value proposition
"Affordable consumer goods and apothecary-style health services with a strong focus on sustainability and private-label value."
Where it wins
- Price and accessibility: 5,209 stores across Europe and 2,342 in Germany alone ensure daily access for ~2 million shoppers per day [1].
- Private-label depth: 27 own brands covering 5,500+ products allow tight price control and margin retention [1].
- Digital health wedge: Launching the "ROSSMANN-Apotheke" by end-2026 to accept e-prescriptions bridges physical retail and digital healthcare [1].
- Exclusive brand partnerships: Securing exclusive rights to major international brands (e.g., Australia’s MCoBeauty) differentiates the assortment [1].
Credibility: Company homepage and press releases from July–August 2026 [1].
Business model
- High-volume retail: Operates 5,209 stores across Europe, leveraging scale for supplier negotiations [1].
- Private-label dominance: 27 brands with 5,500+ products reduce reliance on third-party margins [1].
- Logistics expansion: Building new regional warehouses (e.g., 59,000 m² in Emstek) to support store density [1].
- Omnichannel integration: Combining physical stores with an online shop and a new digital pharmacy [1].
- Exclusive curation: Securing exclusive rights to popular international brands to drive footfall [1].
Competitive landscape
- dm-drogerie markt: Direct competitor in the German drugstore market; ROSSMANN differentiates via exclusive brands and digital health [1].
- Apotheken (Pharmacies): Traditional healthcare providers; ROSSMANN competes via the new digital pharmacy and e-prescriptions [1].
- Supermarkets: Compete in household goods; ROSSMANN wins on specialized cosmetics and health products [1].
- Online retailers: Compete on convenience; ROSSMANN leverages its physical network and exclusive brands [1].
- International drugstores: Compete in other European markets; ROSSMANN’s scale and private labels provide an edge [1].
Differentiators: Exclusive brand partnerships, extensive private-label portfolio, and early mover in digital pharmacy integration.
Market pains
- Healthcare access: Limited access to affordable health products and prescriptions in rural areas [1].
- Price sensitivity: Consumers seeking affordable personal care and household goods [1].
- Sustainability concerns: Shoppers demanding more sustainable and socially responsible products [1].
- Brand exclusivity: Desire for unique, high-quality international brands not widely available [1].
- Digital convenience: Need for seamless online and offline shopping experiences [1].
Strategic implications
ROSSMANN’s move into digital health via the ROSSMANN-Apotheke is a strategic wedge to capture the growing e-health market and differentiate from traditional retailers. The heavy investment in private labels (27 brands) reduces dependency on third-party suppliers and improves margins. However, the high fixed costs of 5,209 stores pose a risk if foot traffic declines. The next signal to watch is the adoption rate of the e-prescription platform and the success of exclusive brand roll-outs like MCoBeauty in driving new customer segments.
Improvement suggestions
Expand the private-label portfolio into high-growth categories like sustainable home care to further differentiate from dm. Accelerate the digital pharmacy rollout by integrating with more healthcare providers to increase e-prescription volume. Enhance the online shopping experience with personalized recommendations based on purchase history to compete with pure-play e-commerce. Leverage the Viva con Agua partnership to launch more social impact products, appealing to sustainability-conscious consumers.